ProstaLund will offer patients with benign prostate enlargement an individually tailored, non-surgical treatment that is potent, safe, painless and cost-effective.
ProstaLund is a Swedish medtech company, a leader in the development of innovative products and treatments in urology. ProstaLund has patented CoreTherm®, an individualized thermotherapy treatment for benign prostatic hyperplasia (Benign Prostatic Hyperplasia - BPH). CoreTherm® is used today in hospitals and outpatient clinics in Sweden and around the world.
Read more about ProstaLund's new product CoreFlow® - Soft Stent
Prostalund AB includes the subsidiary Nordisk Medicin & Teknik AB. The company provides innovative and cost-effective products with good quality to simplify work in healthcare in the Nordic region.